Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis.

Mikulska M, Giacobbe DR, Furfaro E, Mesini A, Marchese A, Del Bono V, Viscoli C.

Clin Microbiol Infect. 2016 Jul;22(7):646.e5-8. doi: 10.1016/j.cmi.2016.05.020. Epub 2016 May 30.

2.

Candida biomarkers in patients with candidaemia and bacteraemia.

Martínez-Jiménez MC, Muñoz P, Valerio M, Alonso R, Martos C, Guinea J, Bouza E.

J Antimicrob Chemother. 2015 Aug;70(8):2354-61. doi: 10.1093/jac/dkv090. Epub 2015 Apr 21.

PMID:
25900160
3.

Value of (1-3)-β-d-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia.

Mokaddas E, Khan ZU, Ahmad S, Nampoory MR, Burhamah M.

Clin Microbiol Infect. 2011 Oct;17(10):1549-53. doi: 10.1111/j.1469-0691.2011.03608.x. Epub 2011 Aug 29.

4.

Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.

Poissy J, Sendid B, Damiens S, Ichi Ishibashi K, François N, Kauv M, Favory R, Mathieu D, Poulain D.

Crit Care. 2014 Jun 29;18(3):R135. doi: 10.1186/cc13953.

5.

Diagnostic accuracy of fungal PCR and β-d-glucan for detection of candidaemia: a preliminary evaluation.

McKeating C, White PL, Posso R, Palmer M, Johnson E, McMullan R.

J Clin Pathol. 2018 May;71(5):420-424. doi: 10.1136/jclinpath-2017-204692. Epub 2017 Sep 28.

PMID:
28970296
6.

Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.

Held J, Kohlberger I, Rappold E, Busse Grawitz A, Häcker G.

J Clin Microbiol. 2013 Apr;51(4):1158-64. doi: 10.1128/JCM.02473-12. Epub 2013 Jan 30.

7.

Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.

Giacobbe DR, Esteves P, Bruzzi P, Mikulska M, Furfaro E, Mesini A, Tatarelli P, Grignolo S, Viscoli C, Colombo AL, Del Bono V.

Clin Microbiol Infect. 2015 Oct;21(10):954.e9-17. doi: 10.1016/j.cmi.2015.06.002. Epub 2015 Jun 10.

8.

Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.

Prüller F, Wagner J, Raggam RB, Hoenigl M, Kessler HH, Truschnig-Wilders M, Krause R.

Med Mycol. 2014 Jul;52(5):455-61. doi: 10.1093/mmy/myu023. Epub 2014 Jun 6.

PMID:
24906361
9.

Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.

Giacobbe DR, Mikulska M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, Mesini A, De Pascale G, Marchese A, Bruzzone M, Pelosi P, Mussap M, Molin A, Antonelli M, Posteraro B, Sanguinetti M, Viscoli C, Del Bono V; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Crit Care. 2017 Jul 10;21(1):176. doi: 10.1186/s13054-017-1763-5.

11.

Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.

Montagna MT, Coretti C, Lovero G, De Giglio O, Montagna O, Laforgia N, Santoro N, Caggiano G.

Int J Mol Sci. 2011;12(9):5871-7. doi: 10.3390/ijms12095871. Epub 2011 Sep 14.

12.

Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.

Friedrich R, Rappold E, Bogdan C, Held J.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00464-18. doi: 10.1128/JCM.00464-18. Print 2018 Sep.

13.

Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa.

Chibabhai V, Fadana V, Bosman N, Nana T.

Mycoses. 2019 Nov;62(11):1023-1028. doi: 10.1111/myc.12982. Epub 2019 Sep 2.

PMID:
31393662
14.

Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.

Abe M, Kimura M, Araoka H, Taniguchi S, Yoneyama A.

Med Mycol. 2014 Nov;52(8):835-40. doi: 10.1093/mmy/myu066.

PMID:
25349254
15.

Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ.

Clin Infect Dis. 2012 May;54(9):1240-8. doi: 10.1093/cid/cis200. Epub 2012 Mar 19.

PMID:
22431804
16.

Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.

Chen CY, Sheng WH, Huang SY, Chou WC, Yao M, Tang JL, Tsay W, Tien HF, Hsueh PR.

J Antimicrob Chemother. 2015 May;70(5):1531-8. doi: 10.1093/jac/dku540. Epub 2015 Jan 3.

PMID:
25558079
17.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
18.

Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014.

Yeşilkaya A, Azap Ö, Aydın M, Akçil Ok M.

Mycoses. 2017 Jul;60(7):433-439. doi: 10.1111/myc.12618. Epub 2017 Mar 24.

PMID:
28338249
19.

Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.

Lahmer T, Held J, Rasch S, Schnappauf C, Beitz A, Schmid RM, Huber W.

Mycopathologia. 2016 Dec;181(11-12):815-821. Epub 2016 Sep 12.

PMID:
27619810
20.

Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.

Alp S, Arikan-Akdagli S, Gulmez D, Ascioglu S, Uzun O, Akova M.

Mycoses. 2015 Aug;58(8):498-505. doi: 10.1111/myc.12349. Epub 2015 Jul 7.

PMID:
26155849

Supplemental Content

Support Center